Keywords: astrazeneca, set, meet, targets, despite, 1st-qtr, profit
AstraZeneca set to meet 2008 targets, despite 1st-qtr profit decline
Article | 05 May 2008
Anglo-Swedish drug major AstraZeneca's first-quarter 2008 financial results were slightly below expectations, with pretax profit down 5% (-15% at constant exchange rates) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
